Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-29 @ 1:04 AM
Study NCT ID:
NCT04793061
Status:
UNKNOWN
Last Update Posted:
2021-03-11
First Post:
2021-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)
Sponsor:
Elisabethinen Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-09
First Submit QC Date:
None
Study First Post Date:
2021-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-09
Last Update Post Date:
2021-03-11
Last Update Post Date Type:
ACTUAL